Neeraj Narula, MD, MPH, FRCP(C)
Director of the IBD Clinic
Hamilton Health Sciences;
Assistant Professor of Medicine
Dustin Loomes, MD, FRCP(C)
Director, Vancouver Island IBD Clinic
Clinical Assistant Professor, Faculty of Medicine
University of British Columbia
Island Health Authority
Chantal Vaillancourt, RN, BScN
Clinical Nurse Specialist- IBD
Usha Chauhan, NP, MN, BScN, ACNP(D), CGN(C)
Adult Nurse Practitioner at the Digestive Disease Clinic
McMaster University Medical Centre
Saturday, November 20, 2021
12:30 pm - 1:15 pm
Concurrent Session #4:
How To Optimally Transition Your Patients From Biologic To Biosimilar
To review the successful approach to biosimilar switching taken in B.C., and how to learn from this experience to achieve optimal biosimilar switching in Ontario.
Introduction and Evidence to Support Non-Medical Biosimilar Switching
Introduce the symposium and review some key evidence supporting non-medical biosimilar switching.
Dr. Neeraj Narula is an Associate Professor of Medicine and the Director of the IBD Clinic at McMaster University and a Staff Gastroenterologist at Hamilton Health Sciences. He completed the Present-Levison Advanced IBD fellowship in Mount Sinai Medical Centre in New York, NY, in 2015. He trained to be a Chartered Accountant at the University of Waterloo and has worked at Ernst & Young and KPMG. He subsequently attended medical school at the University of Alberta. He completed internal medicine residency and gastroenterology fellowship training at McMaster University. He also obtained a Masters in Public Health at Harvard TH Chan School of Public Health. His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD. He has over 90 peer-reviewed publications in the field of IBD and authored 4 textbook chapters.
Reviewing the British Columbia Experience - The GI’s Perspective
Describe how Vancouver led the way to successful biosimilar switching and discuss why the approach taken there worked.
Dr. Dustin Loomes is an IBD specialist practicing in Victoria, British Columbia. He acts as a Director of the Vancouver Island IBD Clinic, participates in research as a clinical trial investigator, and is an Associate Clinical Faculty with the University of British Columbia and University of Victoria with an active role in teaching. He has authored scientific papers and has co-authored a book entitled “Top Trials in Gastroenterology and Hepatology”, now in its third edition.
Reviewing the British Columbia Experience: The Nurse’s perspective and the patient experience
Describe the Vancouver success with biosimilar switching from the nurse’s perspective so that centres in Ontario can learn from these experiences and optimize the patient experience.
Chantal Vaillancourt attained a Bachelor of Science in Nursing degree with honors from the University of Windsor. She has been working at PerCuro Clinic since 2006 as a Clinical research nurse and Nurse clinician with a focus in Autoimmune disease and gastroenterology. She has been working as an IBD Clinical nurse specialist since 2015.
Talking to Patients About Biosimilars
Review ways in which patients can be involved in and prepared for their switch to a biosimilar.
Usha Chauhan is Adult Nurse Practitioner at Hamilton Health Sciences (HHS), McMaster University Medical Centre, working fulltime in the Digestive Disease clinic with primary focusing on patients with Inflammatory Bowel Disease. Usha also holds a joint position as assistant clinical professor with the School of Nursing at McMaster University
Usha trained in the UK as Registered Nurse, Registered Sick Children’s Nurse and a midwife, received her Bachelor of Science Nursing from Daemen Collage in Amherst New York. She is Canadian Certified Gastroenterology Nurse, has Masters of Nursing and Acute Care Nurse Practitioner Diploma from University of Toronto.
Usha has worked as Gastroenterology nurse 30 years as research study coordinator, outpatient clinic nurse and now as Nurse Practitioner. As a research study coordinator was involved in numerous clinical trials of upper and lower functional disorders including gastric pacemaker study. Has worked adult nurse practitioner since 2009 years focusing in inflammatory bowel disease. She was recipient of the HHS Nightingale award in 2019.
Usha has served on a number of national and international GI nursing committee including Canada Center director and National secretary for Canadian Society Gastroenterology Nurses and Associates (CSGNA), Nurse-European Crohn’s Colitis Organization (NECCO) committee as an international representative; and currently as steering committee member of the Canadian IBD (CANIBD) nurses group.